XML 57 R40.htm IDEA: XBRL DOCUMENT
v3.24.1

Stock-Based Compensation (Details Narrative) - USD ($) |  |  |  |  |  |  |  |  |  |  |  | 12 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Sep. 26, 2023 | Jun. 30, 2023 | Nov. 06, 2022 | Jun. 30, 2022 | Jun. 17, 2022 | Jun. 30, 2021 | May 11, 2021 | Apr. 09, 2021 | Aug. 12, 2020 | Aug. 01, 2020 | Jul. 15, 2020 | Dec. 31, 2023 | Dec. 31, 2022 | Nov. 27, 2023 | Nov. 26, 2023 | Oct. 07, 2022 | Oct. 06, 2022 | Dec. 31, 2021 | Jul. 14, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares outstanding |  |  |  |  |  |  |  |  |  |  |  | 552,083 | 389,479 |  |  |  |  | 266,667 |
Number of fully vested option exercisable |  |  |  |  |  |  |  |  |  |  |  | 252,292 | 281,979 |  |  |  |  |  |
Deferred compensation expense for unvested stock options |  |  |  |  |  |  |  |  |  |  |  | $ 670,000 |  |  |  |  |  |  |
Weighted-average recognition period |  |  |  |  |  |  |  |  |  |  |  | 26 months |  |  |  |  |  |  |
Fair market value, per share |  |  |  |  |  |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |
Intrinsic value |  |  |  |  |  |  |  |  |  |  |  | $ 8,000 |  |  |  |  |  |  |
Outstanding stock options to acquire shares of common stock not vested |  |  |  |  |  |  |  |  |  |  |  | 299,791 |  |  |  |  |  |  |
Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  | 10,000 |  | 10,000 |  | 10,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  | $ 20.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Five Non Officer Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  | $ 30.30 |  |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  |  | vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  | $ 1,421,095 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  | $ 28.423 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | $ 211,413 | $ 638,915 |  |  |  |  |  |
BasvanderBaan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  | $ 7.40 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  | vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  | $ 158,525 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  | $ 6.341 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | 38,885 | 100,249 |  |  |  |  |  |
Stock options granted to purchase common stock, issued |  |  |  |  | $ 79,263 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Five Non-Officer Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  | $ 7.40 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  | vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  | $ 316,700 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  | $ 6.334 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | 94,881 | 63,777 |  |  |  |  |  |
Four Officers [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  | 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  | vesting 25% on issuance and 25% on each anniversary date thereafter until fully vested, subject to continued service |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  | $ 262,560 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  | $ 3.282 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | 61,448 | 75,520 |  |  |  |  |  |
Number of fully vested option exercisable |  |  | 80,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options granted to purchase common stock, issued |  |  | 80,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Four Non-officer Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  | 40,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  | $ 5.88 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  | vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  | $ 192,593 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  | $ 4.8131 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | 48,464 |  |  |  |  |  |  |
Eric J. Forman [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  |  |  |  |  |  |  | 5,833 |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  |  |  |  |  | $ 71.40 |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  |  |  |  |  |  |  | The options vested 25% on August 12, 2020, 2021 and 2022, respectively, with the final 25% vesting on August 12, 2023 |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  |  |  |  |  | $ 400,855 |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  |  |  |  |  | $ 68.718 |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  |  |  | $ 100,214 |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | 61,501 | 100,213 |  |  |  |  |  |
Dr.James S. Miser [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  |  |  |  |  |  | 8,333 |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  |  |  |  | $ 71.40 |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  |  |  |  |  |  | The options vested 25% on August 1, 2020, 2021 and 2022, respectively, with the final 25% vesting on August 1, 2023 |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  |  |  |  | $ 572,650 |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  |  |  |  | $ 68.718 |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  |  |  |  | $ 143,163 |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | $ 83,544 | 143,163 |  |  |  |  |  |
Robert N. Weingarten [Member] | Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  |  |  |  |  | 5,833 |  |  |  |  |  |  |  |  |  |
Robert N. Weingarten [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  |  |  | $ 71.40 |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  |  |  |  |  |  |  |  | The options vested 25% on August 12, 2020, 2021 and 2022, respectively, with the final 25% vesting on August 12, 2023 |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  |  |  | $ 400,855 |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  |  |  | $ 68.718 |  |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  |  |  | $ 100,214 |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | $ 61,501 | 100,213 |  |  |  |  |  |
Mr Schwartberg [Member] | Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  |  |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  |  | $ 32.00 |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  |  |  |  | vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  |  | $ 753,611 |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  |  | $ 30.144 |  |  |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  |  | $ 376,800 |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | 126,684 |  |  |  |  |  |
Ms.Regina Brown [Member] | Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  |  |  |  |  | 25,000 |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  | $ 28.00 |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term |  |  |  |  |  |  | vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  | $ 658,363 |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  | $ 26.335 |  |  |  |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  | $ 329,188 |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | 76,388 | $ 154,042 |  |  |  |  |  |
Bio Pharma Works LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross |  |  | 10,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  | $ 5.025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  | $ 43,264 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  | $ 4.326 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
BasvanderBaan [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options, grants in period, gross | 250,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option exercisable period | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share | $ 1.95 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options | $ 403,066 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share | $ 1.612 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  | $ 35,178 |  |  |  |  |  |  |
Mr Van der Baan [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options vesting term | The options vest in equal increments quarterly over a three-year period commencing on the last day of each calendar quarter commencing October 1, 2023, subject to continued service |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
2020 Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issuable |  |  |  |  |  |  |  |  |  |  |  |  |  | 750,000 | 336,667 | 413,333 | 180,000 |  | 233,333
Shares outstanding |  |  |  |  |  |  |  |  |  |  |  | 495,000 |  |  |  |  |  |  |
Shares were available for issuance |  |  |  |  |  |  |  |  |  |  |  | 255,000 |  |  |  |  |  |  |

X
- Definition Fair value of stock options. + References No definition available. + Details
Name: | LIXT_FairValueOfStockOptions
Namespace Prefix: | LIXT_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award options outstanding period increase decrease value. + References No definition available. + Details
Name: | LIXT_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseValue
Namespace Prefix: | LIXT_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The compensation expense recognized during the period pertaining to the deferred compensation arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 710 -SubTopic 10 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483043/710-10-30-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 1D -Publisher FASB -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(02) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(03) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(v) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Gross number of share options (or share units) granted during the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of options outstanding, including both vested and non-vested options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of non-vested options outstanding. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_FiveNonOfficerDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_BasvanderBaanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_FiveNonOfficerDirectorsOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_FourOfficersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_FourNonOfficerDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_EricJFormanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=LIXT_EmploymentAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_DrJamesSMiserMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_RobertNWeingartenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_MrSchwartbergMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_MsReginaBrownMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_BioPharmaWorksLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_BasvanderBaanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_MrVanderBaanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=LIXT_TwoThousandTwentyStockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |